Work herein shows that Fgl2 secreted by macrophages is a consequential binding partner of FcγRIIB on CD8+ T cells and functions during melanoma challenge to decrease tumor control through reducing the pool of tumor-specific CD8+ T cells. The gene discussed is FGL2; the disease is melanoma.